Showing results (531-540 of 549) with videos related to

Sort By:
Pageof 55
Nature Medicine|October 1, 2025
Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsisOliver Liesenfeld, Sanjay Arora, Tom P Aufderheide, et al.
Annals of Neurology|June 13, 2019
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementationViorica Chelban, Matthew P Wilson, Jodi Warman Chardon, et al.
Journal of Clinical Microbiology|August 27, 2025
Analytical evaluation of TriVerity, a rapid diagnostic and prognostic host gene expression test performed on the Myrna instrument using RT-LAMPClaudia Figueiredo-Pereira, Paul Fleming, Mikaela Nicole Alganes, et al.
Journal of Clinical Medicine|April 9, 2024
Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic InflammationRobert Balk, Annette M Esper, Greg S Martin, et al.
Journal of Clinical Medicine|October 26, 2024
Rapid and Robust Identification of Sepsis Using SeptiCyte RAPID in a Heterogeneous Patient PopulationRobert Balk, Annette M Esper, Greg S Martin, et al.
JCI Insight|March 29, 2022
IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial functionLivia Casciola-Rosen, David R Thiemann, Felipe Andrade, et al.
JAMA|February 23, 2021
Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical TrialJonathan E Sevransky, Richard E Rothman, David N Hager, et al.
American Journal of Respiratory and Critical Care Medicine|April 7, 2018
Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICURussell R Miller, Bert K Lopansri, John P Burke, et al.
Plos Biology|May 7, 2021
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2Chantal B F Vogels, Mallery I Breban, Isabel M Ott, et al.
Vaccine|November 16, 2023
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023Ian D Plumb, Melissa Briggs Hagen, Ryan Wiegand, et al.
Pageof 55